Bausch & Lomb (BLCO) Total Non-Current Liabilities (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Total Non-Current Liabilities came in at $7.0 billion in Q2 2026, down 3.43% YoY from $7.2 billion in Q2 2025, and up 1.6% on a QoQ basis from $6.9 billion in Q1 2026.
Bausch & Lomb (BLCO) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Total Non-Current Liabilities data on file, last reported at $7.0 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 3.43% year-over-year to $7.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.0 billion (down 3.43% YoY) and the FY2025 annual result came in at $7.0 billion, up 7.5% from the prior year.
- Total Non-Current Liabilities grew to $7.0 billion in Q2 2026, from $6.9 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $7.2 billion in Q2 2025 to a low of $3.7 billion in Q1 2022.
- A 5-year average of $5.8 billion and a median of $6.5 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 230.72% — and 2026, when it decreased 3.43%.
- Tracing BLCO's Total Non-Current Liabilities over 5 years: stood at $3.7 billion in 2022, then soared by 64.92% to $6.1 billion in 2023, then increased by 6.04% to $6.5 billion in 2024, then gained by 7.5% to $7.0 billion in 2025, then slipped by 0.03% to $7.0 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $7.0 billion (Q2 2026), $6.9 billion (Q1 2026), and $7.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 6.98 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.98 Bn |
| Mar 31, 2026 | 6.87 Bn |
| Dec 31, 2025 | 6.98 Bn |
| Sep 30, 2025 | 6.83 Bn |
| Jun 30, 2025 | 7.23 Bn |
| Mar 31, 2025 | 6.88 Bn |
| Dec 31, 2024 | 6.50 Bn |
| Sep 30, 2024 | 6.81 Bn |
| Jun 30, 2024 | 6.63 Bn |
| Mar 31, 2024 | 6.52 Bn |
| Dec 31, 2023 | 6.13 Bn |
| Sep 30, 2023 | 6.14 Bn |
| Jun 30, 2023 | 4.28 Bn |
| Mar 31, 2023 | 4.11 Bn |
| Dec 31, 2022 | 3.71 Bn |
| Sep 30, 2022 | 3.90 Bn |
| Jun 30, 2022 | 4.03 Bn |
| Mar 31, 2022 | 3.68 Bn |
| Dec 31, 2021 | 1.12 Bn |